期刊文献+

1型登革病毒抗原表位嵌合人3型腺病毒六邻体重组病毒的构建及免疫学鉴定 被引量:1

Construction and characterization of a hexon-chimeric human adenovirus type 3 vector expressing one major epitope of dengue virus type 1
原文传递
导出
摘要 目的构建六邻体嵌入1型登革病毒(DENVI)抗坂表位的人3型重组腺病毒,鉴定其抗原性。方法以人3型腺病毒骨架质粒pBRAd△E3GFP为模板,overlap PCR在六邻体高变区HVR1插入DENV1的抗原表位,突变的六邻体片段克隆到穿梭载体,酶切后与线性化的3型腺病毒骨架质粒pBRAd△E3GFP在大肠杆菌BJ5183同源重组,获得阳性重组腺病毒质粒pBRAd△E3GFP-DENV1。线性化后转染AD293细胞拯救重组腺病毒rAd△E3GFP-DENV1并大量培养。纯化后腺病毒免疫BALB/c小鼠,通过ELISA和Western blot检测小鼠的体液免疫应答。结果在人3型腺病毒六邻体成功插入DENV1抗坂表位并包装出重组腺病毒,ELISA和Westernblot结果显示小鼠免疫后能产生血清识别DENV1。结论成功构建六邻体HVR1嵌入DENV1抗原表位的重组腺病毒,为多价登革病毒疫苗的研究奠定了基础。 Objective To construct a recombinant human adenovirus type 3 (HAd3) vector ex- pressing one major epitope of dengue virus type 1. Methods The gene encoding the envelope protein (304- 314 aa) of dengue virus type 1 was inserted into the hypervariable region 1 (HVR1) of HAd3 hexon by using overlap PCR. The recombinant gene was cloned into the shuttle plasmid, then linearized with Asis I restriction enzyme and co-transformed into Escherichia coli BJ5183 strains with the digested backbone plas- mid for homologous reemnbination. The recombinant plasmid pBRAd△E3GFP-DENV1 was transfeeted into AD293 cells to rescue recombinant adenovirus strains (rAd△E3GFP-DENV1). ELISA and Western blot as- say were performed to evaluate the bumoral responses induced in BALB/c mice after the immunization with rAd△E3GFP-DENV1 strains. Results The recombinant adenovirus strains were successfully rescued. ELISA and Western blot assay showed that the antibodies in serum sample could recognize dengue virus type 1 strains. Conclusion The recombinant adenovirus strains expressing the epitope of dengue virus type 1 were successfully constructed, This study provided evidence for the development of multivalent vaccines against dengue virus.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2015年第6期464-468,共5页 Chinese Journal of Microbiology and Immunology
基金 国家自然科学基金青年科学基金(31200132) 广州市科技计划项目(2013J4100038)
关键词 腺病毒 六邻体 高变区 登革病毒 抗原表位 Adenovirus Hexon Hypervariable region Dengue virus Epitope
  • 相关文献

参考文献12

  • 1Worgall S, Krause A, Rivara M, et al. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid[J]. J Clin Invest, 2005, 115(5): 1281-1289.
  • 2Zaiss AK, Machado HB, Herschman HR. The influence of innate and pre-existing immunity on adenovirus therapy [ J ]. J Cell Biochem, 2009, 108(4) : 778-790.
  • 3Matthews QL. Capsid-incorporation of antigens into adenovirus capsid proteins for a vaeeine approaeh[J]. Mol Pharm, 2011, 8 (1): 3-11.
  • 4Rux JJ, Kuser PR, Burnett RM. Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallo- graphic:, molecular modeling, and sequence-based methods[ J].J Virol, 2003, 77(17) : 9553-9566.
  • 5Guzman MG, Halstead SB, Artsob H, et al. Dengue: a continu- ing global threat [J]. Nat Rev Microbiul, 2010, 8 ( 12 Suppl ) : S7-S16.
  • 6Thullier P, Demangel C, Bedouelle H, el al. Mapping of a den- gue virus neutralizing epitope critical for the infectivity of all sero- types: insight into the neutralization mechanism[ J]. J Gen Virnl, 2001, 82(Pt 8) : 1885-1892.
  • 7McConnell MJ, Danthinne X, Imperiale MJ. Characterization of a permissive epitope insertion site in adenovirus hexon[ J]. J Virol, 2006, 80( 11 ) : 5361-5370.
  • 8Krause A, Joh JH, Hackett NR, et al. Epitopes expressed in dif- ferent adenovirus eapsid proteins induce different levels of epitope- specific immunity [ J ]. J Virol, 2006, 80 ( 11 ) : 5523-5530.
  • 9Hemminki O, Bauersehmitz G, Hemmi S, et al. Oncoly|ic adeno- virus based on serotype 3[J]. Cancer Gene Ther, 2011 , 18(4) : 288 -296.
  • 10周志超,梁焕喜,李婷,钟田花,田新贵,周荣,李潇.人3型腺病毒六邻体高变区HVR1、HVR2、HVR5、HVR7的氨基酸修饰限制研究[J].病毒学报,2012,28(4):372-381. 被引量:3

共引文献2

同被引文献25

  • 1周玉,李岩松,潘风光,谭建华,柳增善,王哲.小鼠腹水IgG类单克隆抗体纯化方法的研究[J].黑龙江畜牧兽医,2006(10):14-16. 被引量:34
  • 2Gui J, Liu Z, Zhang T, et al. Epidemiological characteristics and spatial-temporal clusters of hand, foot, and mouth disease in Zhejiang Province, China, 2008 -2012[J/OL]. PLoS One, 2015, 10 ( 9 ) : e0139109, doi: 10. 1371/journal. pone. 0139109. eCollection 2015.
  • 3Iai F F, Yan Q, Ge S X, et al. Epiderr, iologic and etiologic characteristics of hand, foot, and mouth disease in Chongqing, China between 2010 and 2013[J]. J Med Virol, 2016, 88(3) : 408 -416.
  • 4Mao Q Y, Wang Y, Bian L, et al. EV71 vaccine, a new tool to control outbreaks of hand, foot and mouth disease ( HFMD ) [ J ]. Expert Rev Vaccines, 2016, 15(5) : 599 -606.
  • 5Reed Z, Cardosa M J. Status of research and development of vaccines for entemvirus 71[J]. Vaccine, 2016, 34(26): 2967-2970.
  • 6kiener T K, Jia Q, Meng T, et al. A novel universal neutralizing monoclonal antibody against enterovirus 71 that targets the highly conserved "knob" region of VP3 protein [ J/OL ]. PLoS Negl Trap Dis, 2014, 8 (5) : e2895, doi: 10. 1371/journal. pntd. 0002895. eCollectian 2014.
  • 7Lira X F, Jia Q, Kbong W X, et al. Characterization of an isotype- dependent monoclonal antibody against linear neutralizing epitope effective for prophylaxis of enterovirus 71 infection [ J/OL]. PLoS One, 2012, 7 ( 1 ) : e29751, doi: 10. 1371/journal. pone. 0029751. Epub 2012 Jan 18.
  • 8Xu L, Huang K J, Ho T S, et al. Monoclonal antibodies for diagnosis of enterovirus 71 [ J]. Monoclon Antib Immunodiagn Immunother, 2013, 32(6) : 386 -389.
  • 9Deng Y Q, Ma J, Xu L J, et al. Generation and characterization of a protective mouse monoclonal antibody against human entemvirus 71 [J]. Appl Microbiol Biotechnol, 2015, 99(18): 7663-7671.
  • 10Bible J M, Itmriza-Gorrkara M, Megson B, et al. Molectdar epidemiology of hurmn entemvims 71 in the United Kingdom from 1998 to 2006[ J]. J Clin Microbiol, 2008, 46(10) : 3192 -3200.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部